Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells

Cancer Science

Volumn 103, Issue 4, 2012, Pages 797-805

  Fuyuhiro, Yuhiko ^a   Yashiro, Masakazu ^a   Noda, Satoru ^a   Matsuoka, Junko ^a   Hasegawa, Tsuyoshi ^a   Kato, Yukihiro ^a   Sawada, Tetsuji ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; NEUTRALIZING ANTIBODY; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER ASSOCIATED ORTHOTOPIC FIBROBLAST; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE MICROSCOPY; INVASION ASSAY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; WOUND HEALING ASSAY;

CADHERINS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; FIBROBLASTS; HUMANS; MYOFIBROBLASTS; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 84863396831     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02209.x     Document Type: Article

References (24)

1. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
2. Yashiro M, Hirakawa K. Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron 2010; 3: 127-35.
3. Inoue T, Chung YS, Yashiro M et al. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 1997; 88: 152-9.
4. Semba S, Kodama Y, Ohnuma K et al. Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells. Br J Cancer 2009; 101: 1365-73.
5. Saito H, Tsujitani S, Oka S et al. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma. Anticancer Res 2000; 20: 4489-93.
6. Massagué J. TGFbeta in cancer. Cell 2008; 134: 215-30.
7. Yang L, Moses HL. Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? Cancer Res 2008; 68: 9107-11.
8. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54.
9. Heldin CH, Miyazono K, Ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465-71.
10. Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M. Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 1996; 74: 1406-12.
11. Kato Y, Yashiro M, Noda S et al. Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. Br J Cancer 2010; 102: 898-907.
12. Motoyama T, Hojo H, Watanabe H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 1986; 36: 65-83.
13. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
14. Kawajiri H, Yashiro M, Shinto O et al. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 2008; 14: 2850-60.
15. Fuyuhiro Y, Yashiro M, Noda S et al. Myofibroblasts are associated with the progression of scirrhous gastric carcinoma. Exp Ther Med 2010; 1: 547-51.
16. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-52.
17. Cat B, Stuhlmann D, Steinbrenner H et al. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 2006; 119: 2727-38.
18. De WeverO, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008; 123: 2229-38.
19. De WeverO, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-47.
20. Iwatsuki H, Sasaki K, Suda M, Itano C. Vimentin intermediate filament protein as differentiation marker of optic vesicle epithelium in the chick embryo. Acta Histochem 1999; 101: 369-82.
21. Gilles C, Polette M, Mestdagt M et al. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 2003; 63: 2658-64.
22. Korsching E, Packeisen J, Liedtke C et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 2005; 206: 451-7.
23. Fuyuhiro Y, Yashiro M, Noda S et al. Clinical significance of vimentin-positive gastric cancer cells. Anticancer Res 2010; 30: 5239-43.
24. Fuyuhiro Y, Yashiro M, Noda S et al. Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells. Br J Cancer 2011; 105: 996-1001.